Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
China · Delayed Price · Currency is CNY 39.79
+1.54 (4.03%)
At close: Apr 21, 2026
SHA:688163 Market Cap
SHA:688163 has a market cap or net worth of 4.31 billion as of April 21, 2026. Its market cap has increased by 131.61% in one year.
Market Cap
4.31B
Enterprise Value
3.52B
Revenue
196.21M
Ranking
n/a
PE Ratio
82.90
Stock Price
39.79
Market Cap Chart
Since March 11, 2022, SHA:688163's market cap has decreased from 5.98B to 4.31B, a decrease of -28.05%. That is a compound annual growth rate of -7.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 4.31B | 82.77% |
| Dec 31, 2025 | 2.36B | 23.97% |
| Dec 31, 2024 | 1.90B | -12.16% |
| Dec 29, 2023 | 2.16B | -5.22% |
| Dec 30, 2022 | 2.28B | -61.86% |
| Mar 11, 2022 | 5.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guanhao Biotech | 3.98B |
| Boji Medical Technology | 3.90B |
| Qingdao Vland Biotech INC. | 3.84B |
| Zhejiang Wecome Pharmaceutical Company | 3.79B |
| Baolingbao Biology | 3.75B |
| Shanghai Shen Lian Biomedical | 3.69B |
| Zhejiang Shouxiangu Pharmaceutical | 3.67B |
| Beijing Kawin Technology Share-Holding | 3.55B |